Camp4 Therapeutics Corp financial data

Symbol
CAMP on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 05 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 765% %
Debt-to-equity 61% %
Return On Equity -162% % -397%
Return On Assets -101% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 51,919,321 shares 158%
Common Stock, Shares, Outstanding 51,902,614 shares 158%
Entity Public Float $14,600,000 USD
Common Stock, Value, Issued $6,000 USD 200%
Weighted Average Number of Shares Outstanding, Basic 30,380,567 shares 548%
Weighted Average Number of Shares Outstanding, Diluted 30,380,567 shares 548%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $795,000 USD
Research and Development Expense $38,202,000 USD -1.6%
General and Administrative Expense $17,357,000 USD 16%
Operating Income (Loss) $52,555,000 USD 1%
Nonoperating Income (Expense) $27,848,000 USD -2247%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $80,403,000 USD -55%
Earnings Per Share, Basic -2.65 USD/shares 76%
Earnings Per Share, Diluted -2.65 USD/shares 76%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $109,517,000 USD 71%
Accounts Receivable, after Allowance for Credit Loss, Current $1,000,000 USD
Other Assets, Current $342,000 USD 62%
Assets, Current $114,095,000 USD 72%
Property, Plant and Equipment, Net $2,895,000 USD
Operating Lease, Right-of-Use Asset $397,000 USD -93%
Other Assets, Noncurrent $83,000 USD -81%
Assets $117,808,000 USD 50%
Accounts Payable, Current $182,000 USD -85%
Employee-related Liabilities, Current $2,642,000 USD -15%
Accrued Liabilities, Current $5,632,000 USD 17%
Contract with Customer, Liability, Current $9,387,000 USD 2338%
Liabilities, Current $15,514,000 USD 62%
Contract with Customer, Liability, Noncurrent $8,113,000 USD
Operating Lease, Liability, Noncurrent $1,688,000 USD -69%
Other Liabilities, Noncurrent $29,000 USD -60%
Liabilities $70,104,000 USD 362%
Retained Earnings (Accumulated Deficit) $292,156,000 USD -38%
Stockholders' Equity Attributable to Parent $47,704,000 USD -24%
Liabilities and Equity $117,808,000 USD 50%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $14,286,000 USD -28%
Net Cash Provided by (Used in) Financing Activities $151,000 USD 25%
Net Cash Provided by (Used in) Investing Activities $279,000 USD -1760%
Common Stock, Shares Authorized 175,000,000 shares 0%
Common Stock, Shares, Issued 51,902,614 shares 157%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $14,716,000 USD -30%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $111,757,000 USD 70%
Deferred Tax Assets, Valuation Allowance $76,140,000 USD 17%
Deferred Tax Assets, Gross $76,246,000 USD 15%
Operating Lease, Liability $1,974,000 USD -77%
Payments to Acquire Property, Plant, and Equipment $279,000 USD 1760%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $80,403,000 USD -55%
Lessee, Operating Lease, Liability, to be Paid $2,061,000 USD -78%
Property, Plant and Equipment, Gross $10,460,000 USD
Operating Lease, Liability, Current $286,000 USD -90%
Lessee, Operating Lease, Liability, to be Paid, Year Two $648,000 USD -82%
Lessee, Operating Lease, Liability, to be Paid, Year One $336,000 USD -90%
Operating Lease, Weighted Average Discount Rate, Percent 0.0687 pure 2.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $87,000 USD -89%
Lessee, Operating Lease, Liability, to be Paid, Year Three $581,000 USD -71%
Deferred Tax Assets, Operating Loss Carryforwards $33,794,000 USD 22%
Preferred Stock, Shares Authorized 25,000,000 shares
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $329,000 USD 25%
Operating Lease, Payments $3,463,000 USD 2.2%
Additional Paid in Capital $339,854,000 USD 24%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $421,000 USD -3.4%
Share-based Payment Arrangement, Expense $3,998,000 USD -0.84%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares